# Efficacy and Safety of Tocotrienols in CADASIL

> **NCT04658823** · PHASE2 · COMPLETED · sponsor: **Hovid Berhad** · enrollment: 50 (actual)

## Conditions studied

- Cadasil

## Interventions

- **DRUG:** HOV-12020 (Palm tocotrienols complex)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04658823
- **Lead sponsor:** Hovid Berhad
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-12-21
- **Primary completion:** 2024-02-28
- **Final completion:** 2024-10-31
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2026-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04658823

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04658823, "Efficacy and Safety of Tocotrienols in CADASIL". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04658823. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*